From West Virginia, USA:
I suspect PCOS and insulin resistance. I recently had my doctor do a glucose tolerance test (GTT) with insulin. Due to an error, the blood sugar was back, but not the insulin yet. My fasting blood sugar has always been 91 to 94 mg/dl [5.1 to 5.2 mmol/L] up until two weeks ago. Then, I became sick just before the GTT. I was started on Albuterol inhaler. My fasting sugar was 126 mg/dl [7.0 mmol/L]. I read this was due to the inhaler.
I have acanthosis nigricans under my arms and at the base of my neck. I also have high triglycerides, obesity, high blood pressure, high cholesterol, hair loss on my scalp, facial hair, which is increasing, and skin tags. Several years ago, I also had a ruptured ovarian cyst and prior to my hysterectomy about 12 years ago, my periods had almost stopped and my estrogen level was high. I am 44 years old. My father has diabetes and heart disease. If a person has acanthosis nigricans, are they always insulin resistant? My cortisol levels and thyroid were all normal.
I think you have already answered this question. Insulin resistance with high insulin levels wold be common in such circumstances, but not 100%. The higher the levels, the more insulin resistant. It is likely that either the illness and/or the inhaler itself caused further insulin resistance and thus the higher blood glucose levels you reported. You may want to consider consulting with a diabetologist for more individualized advice.
Last Updated: Tuesday April 06, 2010 15:10:02
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.